Countdown to VIVA and The VEINS

VIVA20 begins on November 6 in an all-new virtual environment.

Watch the how-to video for a sneak peek overview of the platform and helpful tips for navigating it.

Register now!

Our Mission

VIVA is driven to improve patient care through multidisciplinary collaboration, drawing leaders from all areas of vascular care to move the field forward.

Learn more

Our Board

VIVA's board represents specialists across the spectrum of interventional cardiology, interventional radiology, vascular medicine, and vascular surgery.

See our Board of Directors and Founders

Webinars & More

VIVA now offers select conference content and recorded webinars on our featured videos page.

Learn more

Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.

News & Updates

Results from 10 Highly Anticipated Vascular Interventional Clinical Trials to Be Presented for the First Time at VIVA20

September 9, 2020

SAN JOSE, CA, 9/9/20 -- Leading researchers and physicians will present results from 10 clinical trials that focus on vascular interventional technology and treatment solutions on Friday, November 6, and Saturday, November 7, during the 18th annual VIVA (Vascular InterVentional Advances) conference, which will be held ...

News & Updates

VIVA Announces Virtual Meeting for 2020

July 30, 2020

For 18 years VIVA has set the standard in endovascular education, bringing together leaders from all specialties to advance the field of vascular medicine and intervention, improve patient outcomes, and develop the next generation of experts and innovators. In the unprecedented era of COVID-19, we recognize the ongoing ...

News & Updates

MERLION Trial: First Outcomes of Luminor™ DCB in TASC C&D Tibial Occlusive Disease

June 25, 2020

Physician Initiated, Prospective, Non-randomized Multicenter Trial, Investigating the Safety and Efficacy of the tReatment with the Luminor™ Drug-Coated Balloon and the Angiolite™ Drug Eluting Stent of IVascular in TASC C and D Tibial Occlusive Disease iN Patients with Chronic Limb Threatening Ischemia (MERLION Trial) ...

Official Publication

Endorsements

Virtual VIVA App

Connect. Interact. Engage. Leverage the power of the Virtual VIVA app to access content from VIVA19 from the convenience of your mobile device, which is available to all registrants of the VIVA conference.

Show more